# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cu...
American Express Company has "above market growth for below market multiple," Amy Raskin of Chevy Chase Trust said.
Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.
Stocks initially rose on positive jobless claims report, but dropped later as Fed officials expressed doubts about interest rat...
The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the highs of ...
To gain an edge, this is what you need to know today.
The rebound by biopharma stocks in 2023 and the pickup in M&A news flow makes the 2024 JPMorgan Healthcare conference even ...
Satori Fund founder and portfolio manager Dan Niles is out with his top stock picks for 2024 and two Magnificent 7 names are at...